TTR and diabetes mellitus: Before this is achieved, perhaps the timing and dose of energy and protein intakes should be guided by the surrogates of inflammation resolution, e.g. down-trending of high-sensitivity C-reactive protein, reduced insulin resistance (improved glycaemic control in patients without diabetes [37]), or improvement in organ functions (down-trending of the sequential SOFA scores) [38] and levels of transthyretin [39].